title: Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
abstract: The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty-five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100%, 72.7% and 17.6% in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively.
authors.affiliation: Istituto di Malattie Infettive e Parassitarie degli Animali, Facoltà di Medicina Veterinaria, Università Bari, Italia.
authors.forename: C
authors.initials: C
authors.lastname: Buonavoglia
authors.forename: A
authors.initials: A
authors.lastname: Cavalli
authors.forename: E
authors.initials: E
authors.lastname: Gravino
authors.forename: V
authors.initials: V
authors.lastname: Voigt
authors.forename: D
authors.initials: D
authors.lastname: Buonavoglia
authors.forename: D
authors.initials: D
authors.lastname: de Caprariis
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004283:Dog Diseases / Q000276:immunology / Q000517:prevention & control*; D004285:Dogs; D007112:Immunity, Maternally-Acquired; D010322:Parvoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D017993:Parvovirus, Canine / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D014765:Viral Vaccines